Last reviewed · How we verify

NCT03762525

Iliac Branch Device Movement During Cardiac Cycle (IBD-dynamics)

Completed NA Last updated 12 February 2021
What this trial tests

NA trial testing ECG gated CTA in Iliac Aneurysm in 45 participants. Completed in 31 December 2020.

Timeline
5 October 2016
Primary endpoint
31 December 2020
31 December 2020

Quick facts

Lead sponsorRijnstate Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designsingle group
Maskingnone
Primary purposeother
Enrollment45
Start date5 October 2016
Primary completion31 December 2020
Estimated completion31 December 2020
Sites3 locations across Netherlands

Drugs / interventions tested

Conditions studied

Sponsor

Rijnstate Hospital

Who can join

Eligibility, any sex, with Iliac Aneurysm or Angiography. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The incidence of isolated common iliac artery (CIA) aneurysms is low, but in combination with an abdominal aortic aneurysm (AAA) they are found in approximately 20-40% of cases. Basically, two different endovascular strategies can be applied to treat a CIA aneurysm with, including 1. the coverage and 2. the preservation of blood flow to the internal iliac artery (IIA). Coil and coverage of the IIA is related to ischemic complications, including buttock claudication, erectile dysfunction and the more severe spinal and colonic ischemia. Iliac branched devices (IBD) have been developed to exclude CIA aneurysms preserving the IIA and currently three alternatives are on the market. Clinical results of these devices are promising but loss of patency is not uncommon. The major difference between the two devices is the IIA component. The Cook IBD uses a -non-dedicated IIA component, while in the GORE® EXCLUDER® Iliac Branch Endoprosthesis (Gore IBE device) a dedicated self expanding stent is used. Stresses and forces exerted onto the endograft by aortic pulsatility may have an effect on the durability and functioning of the endograft. Intermittent hinchpoints could also have an effect on stent integrity and stenosis. By evaluating endograft movement during the cardiac cycle (ECG-gated CTA) it is possible to assess the stress and force exerted onto the endograft. This might help gain insight into mechanisms underlying potential endograft failure, and aid procedural planning and the development of future devices with long-term durability. The choice for device is not part of this study.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Differences in Cardiac-Pulsatility-Induced Displacement and Geometry Changes between the Cook ZBIS and Gore IBE: Postoperative Comparison Using ECG-Gated CTA Scans.
    Simmering JA, van Helvert M, van Herwaarden JA, Slump CH, et al · · 2023 · cited 3× · PMID 36766601 · DOI 10.3390/diagnostics13030496

Verify or expand the search:

Other recruiting trials for Iliac Aneurysm

Currently open trials in the same condition.

Other Rijnstate Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03762525.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing